GlassScriptPhysician profile
Michelle D Patel
NPI 1003077942
$1,304.53
in general payments reported to CMS, 2019-2025
13 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.55 · 2021: $286 · 2022: $202 · 2023: $182 · 2024: $160 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $582.62 | 2021-2025 | Clareon Panoptix Pro, Lensx, Clareon |
| Glaukos Corporation | $282.47 | 2021-2023 | Photrexa Cross-Linking Kit |
| W. L. Gore & Associates, INC. | $94.75 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Dompe US, INC. | $74.55 | 2020 | |
| Bausch & Lomb Americas INC. | $64.31 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Abbvie INC. | $39.92 | 2025 | |
| Harrow Eye, LLC | $39.90 | 2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $29.52 | 2022 | |
| Kala Pharmaceuticals, INC. | $24.56 | 2022 | |
| Thea Pharma INC. | $21.23 | 2025 | Iyuzeh |
| Akorn Operating Company LLC | $19.11 | 2021 | |
| Horizon Therapeutics Plc | $17.27 | 2023 | Tepezza |
| Amgen INC. | $14.32 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.